Baseline glycemic control : Patients with higher HbA1c levels may require more aggressive dose escalation, though this must be balanced against tolerability
For 9 long years, I've been warned about being pre-diabetic
Translational perspective for the use of dual GLP-1R/GcgR agonists for obesity Multiple clinical trials involving GLP-1R/GcgR co-agonists are currently underway (Table 1)
Additionally, a personal or family history of specific health issues, such as medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2, is a major red flag
Since semaglutide is relatively new, these data are not available yet
This is the same quality active ingredient used in brand-name products, not research chemicals or unverified substances